Результаты поиска - Ziteng Liang

  • Отображение 1 - 2 результаты of 2
Отмена результатов
  1. 1
    Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1

    Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1 по Shuo Liu, Ziteng Liang, Jianhui Nie, Wei bo Gao, Xinyi Li, Li Zhang, Yuanling Yu, Youchun Wang, Weijin Huang

    Опубликовано 2023-12-01

    From December 2022 to January 2023, SARS-CoV-2 infections caused by BA.5 and BF.7 subvariants of B.1.1.529 (Omicron) spread in China. It is urgently needed to evaluate the protective immune responses in the infected individuals against the current circulating variants to predict the future potential...

    Полное описание

    Полный текст
    Статья

    Добавить в Избранное
    Сохранить в:
  2. 2
    Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

    Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector по Ziteng Liang, Xi Wu, Jiajing Wu, Shuo Liu, Jincheng Tong, Tao Li, Yuanling Yu, Li Zhang, Chenyan Zhao, Qiong Lu, Haiyang Qin, Jianhui Nie, Weijin Huang, Youchun Wang

    Опубликовано 2023-12-01

    The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-throughput neutralization assays are desirable for developing vaccines and drugs against COVID-19. In this study, a high-titre SARS-CoV-2 pseudovirus was successfully packaged by truncating the C-term...

    Полное описание

    Полный текст
    Статья

    Добавить в Избранное
    Сохранить в:

Инструменты поиска: